Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Devices on the agenda at Chicago TABD (Transatlantic Business Dialogue) conference

This article was originally published in Clinica

Executive Summary

European Commissioners Erkki Liikanen (Enterprise) and Pascal Lamy (Trade) were among the 60 or so delegates scheduled to attend the eighth CEOs' conference of the Transatlantic Business Dialogue (TABD), on November 6-8. The event, held annually (2001 excepted), invited CEOs from US and EU-based companies that conduct transatlantic trade to discuss areas of common concern and draft recommendations on variety of trade areas, including devices and healthcare, for the trade administrations in both regions.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT068815

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel